Comprehensive and Personalized Approach to Managing mHSPC: Fitting the Right Pieces for Each Patient

Did you know that limiting genetic testing to castration-resistant disease is subpar to testing at the hormone-sensitive stage in prostate cancer?    Credit available for this activity expires: 01/09/26